MIVACURIUM CHLORIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mivacurium chloride and what is the scope of patent protection?
Mivacurium chloride
is the generic ingredient in three branded drugs marketed by Abbvie, Rising, and Woodward, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are two drug master file entries for mivacurium chloride.
Summary for MIVACURIUM CHLORIDE
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Clinical Trials: | 2 |
Patent Applications: | 1,010 |
DailyMed Link: | MIVACURIUM CHLORIDE at DailyMed |
Recent Clinical Trials for MIVACURIUM CHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jiangsu Nhwa Pharmaceutical Co., Ltd. | Phase 2 |
Tang-Du Hospital | Phase 2 |
Jiangsu Nhwa Pharmaceutical Co., Ltd. | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for MIVACURIUM CHLORIDE
US Patents and Regulatory Information for MIVACURIUM CHLORIDE
Expired US Patents for MIVACURIUM CHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Abbvie | MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINER | mivacurium chloride | INJECTABLE;INJECTION | 020098-002 | Jan 22, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Abbvie | MIVACRON | mivacurium chloride | SOLUTION;INTRAVENOUS | 020098-001 | Jan 22, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |